WahlbergJ.E. (1996). Clinical overview of irritant dermatitis. In The Irritant Contact Dermatitis Syndrome (ed. van der ValkP.G.M., & MaibachH.I.), pp. 1–6. Boca Raton, FL, USA: CRC Press.
3.
DraizeJ.H., WoodwardG., & CalveryH.O. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. Journal of Pharmacology and Experimental Therapeutics82, 377–390.
4.
BasketterD.A., ReynoldsF.S., & YorkM. (1999). Predictive testing in contact dermatitis: irritant dermatitis. Clinics in Dermatology15, 637–644.
5.
YorkM., GriffithsH.A., WhittleE., & BasketterD.A. (1996). Evaluation of a human patch test for the identification and classification of skin irritation potential. Contact Dermatitis34, 204–212.
6.
BothamP.A., EarlL.K., FentemJ.H., RoguetR., & van de SandtJ.J.M. (1998). Alternative methods for skin irritation: the current status. ECVAM skin irritation task force report 1. ATLA26, 195–211.
7.
SpielmannH., LovellW.W., HölzleE., JohnsonB.E., MaurerT., MirandaM.A., PapeW.J.W., SaporaO., & SladowskiD. (1994). In vitro phototoxicity testing. The report and recommendations of ECVAM workshop 2. ATLA22, 314–348.
8.
BothamP.A., ChamberlainM., BarrattM.D., CurrenR.D., EsdaileD.J., GardnerJ.R., GordonV.C., HildebrandB., LewisR.W., LiebschM., LogemannP., OsborneR., PonecM., RégnierJ-F., SteilingW., WalkerA.P., & BallsM. (1995). A prevalidation study on in vitro skin corrosivity testing. The report and recommendations of ECVAM workshop 6. ATLA23, 219–255.
9.
HowesD., GuyR., HadgraftJ., HeylingsJ., HoeckU., KemperF., MaibachH., MartyJ-P., MerkH., ParraJ., RekkasD., RondelliI., SchaeferH., TäuberU., & VerbieseN. (1996). Methods for assessing percutaneous absorption. The report and recommendations of ECVAM workshop 13. ATLA24, 81–106.
10.
EmmettE.A. (1986). Toxic responses of the skin. In Casarett and Doull's Toxicology (ed. KlaassenC.D., AmdurM.O., & DoullJ.), pp. 412–431. New York, USA: Macmillan.
11.
WilkinsonJ.D., & RycroftR.J.G. (1992). Contact dermatitis. In Textbook of Dermatology (ed. ChampionR.H., BurtonJ.L., & EblingF.J.G.), pp. 611–715. Oxford, UK: Blackwell Scientific Publications.
12.
COLIPA (1995). Cosmetic Product Test Guidelines for the Assessment of Human Skin Compatibility, 22 pp. Brussels, Belgium: COLIPA.
13.
OECD (1992). Acute dermal irritation/corrosion. In OECD Guidelines for Testing of Chemicals. Guideline 404, 6 pp. Paris, France: OECD.
14.
European Community (1998). Non-clinical local tolerance testing of medicinal products. In The Rules Governing Medicinal Products in the European Union, Volume 3b, pp. 109–116. Luxembourg: European Community.
15.
OECD (1998). Revised proposal for the harmonization of hazard classification based on irritation/corrosion, 12 pp. Document no. ENV/MC/CHEM/HCL(98)4. Paris, France: OECD.
16.
FentemJ.H., ArcherG.E.B., BallsM., BothamP.A., CurrenR.D., EarlL.K., EsdaileD.J., HolzhütterH-G., & LiebschM. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. II. Results and evaluation by the management team. Toxicology in Vitro12, 483–524.
17.
ECETOC (1995). Skin Irritation and Corrosion: Reference Chemicals Data Bank. Technical Report No. 66, 247 pp. Brussels, Belgium: European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC).
18.
DaviesR.E., HarperK.H., & KynochS.R. (1972). Inter-species variation in dermal reactivity. Journal of the Society of Cosmetic Chemists23, 371–381.
19.
ECETOC (1993). Percutaneous Absorption. Monograph No. 20, 78 pp. Brussels, Belgium: European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC).
20.
MortzC.G., AndersenK.E., & Halkier-SorensenL. (1997). The efficiency of different moisturizers on barrier recovery in hairless mice evaluated by non-invasive bioengineering methods: a model to select the potentially most effective product. Contact Dermatitis36, 297–301.
21.
BasketterD.A., GriffithsH.A., WangX.M., WilhelmK.P., & McFaddenJ. (1996). Individual, ethnic and seasonal variability in irritant susceptibility of skin: the implications for a predictive human patch test. Contact Dermatitis35, 208–213.
22.
JudgeM.R., GriffithsH.A., BasketterD.A., WhiteI.R., RycroftR.J., & McFaddenJ.P. (1996). Variation in response of human skin to irritant challenge. Contact Dermatitis34, 115–117.
23.
FartaschM., SchnetzE., & DiepgenT.L. (1999). Characterization of detergent-induced barrier alterations: effect of barrier cream on irritation. Journal of Investigative Dermatology3, 121–127.
24.
TupkerR.A., WillisC., BerardescaE., LeeC.H., FartaschM., AgnerT., & SerupJ. (1997). Guidelines on sodium lauryl sulfate (SLS) exposure tests: a report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis37, 53–69.
25.
BasketterD.A., ChamberlainM., GriffithsH.A., RowsonM., WhittleE., & YorkM. (1997). The classification of skin irritants by human patch test. Food and Chemical Toxicology35, 845–852.
26.
FroschP.J., & KligmanA.M. (1979). The soap chamber test. Journal of the American Academy of Dermatology1, 35–41.
27.
HuenerA., FartaschM., HornsteinO.P., & DiepgenT.L. (1994). The irritant effect of different metalworking fluids. Contact Dermatitis31, 220–225.
28.
FroschP.J., KurteA., & PilzB. (1993). Efficacy of skin barrier creams. III. The repetitive irritation test (RIT) in humans. Contact Dermatitis29, 113–118.
29.
FroschP.J., & KurteA. (1994). Efficacy of skin barrier creams. IV. The repetitive irritation test (RIT) with a set of four standard irritants. Contact Dermatitis31, 161–168.
30.
PiriläV. (1975). Chamber test versus patch test for epicutaneous testing. Contact Dermatitis1, 48–52.
31.
FartaschM. (1995). Human barrier formation and reaction to irritation. Current Problems in Dermatology23, 95–103.
32.
FartaschM. (1997). Ultrastructure of the epidermal barrier after irritation. Microsurgical Research Techniques37, 193–199.
33.
YangL., Mao-QiangM., TaljebiniM., EliasP.M., & FeingoldK.R. (1995). Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. British Journal of Dermatology133, 679–685.
34.
BettleyF.R. (1972). The irritant effect of detergents. Transactions of St John's Hospital Dermatology Society58, 65–74.
35.
WillisC.M., StephensC.J.M., & WilkinsonJ.D. (1989). Epidermal damage induced by irritants in man: a light and electron microscopic study. Journal of Investigative Dermatology93, 695–699.
36.
WillisC.M., StephensC.J.M., & WilkinsonJ.D. (1993). Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical irritants. Journal of Investigative Dermatology101, 364–370.
37.
FusenigN.E., BoukampP., BreitkreutzD., HülsenA., PetrusevskaS., CeruttiP., & Stan-bridgeE. (1990). In vitro transformation of human skin epithelial cells: role of ras oncogene in malignant progression. Toxicology in Vitro4, 627–634.
38.
BoukampP., PoppS., AltmeyerS., HolsenA., FaschingC., CremerT., & FusenigN.E. (1997). Sustained non-tumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes, Chromosomes and Cancer19, 201–214.
39.
BadenH.P., KubilusJ., KvedarJ.C., SteinbergM.L., & WolmanS.R. (1987). Isolation and characterization of a spontaneously arising long-lived line of human keratinocytes (NM1). In Vitro Cellular and Developmental Biology23, 205–213.
40.
BoukampP., PetrussevskaR.T., BreitkreutzD., HornungJ., MarkhamA., & FusenigN.E. (1988). Normal keratinisation in a spontaneously immortalized aneuploid human keratinocyte cell line. Journal of Cell Biology106, 761–771.
41.
RiceR.H., SteinmannK.E., de GraffenriedL.A., QhinQ., TaylorN., & SchlegelN. (1993). Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes. Molecular Biology14, 185–194.
42.
BreitkreutzD., BoukampP., RyleC.M., StarkH-J., RoopD.R., & FusenigN.E. (1991). Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Research51, 4402–4409.
43.
BreitkreutzD., SchoopV.M., MiranceaN., BaurM., StarkH-J., & FusenigN.E. (1998). Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. European Journal of Cell Biology75, 1–14.
44.
RyleC.M., BreitkreutzD., StarkH-J., LeighI.M., SteinertP.M., RoopD., & FusenigN.E. (1989). Density-dependent modulation of synthesis of keratins 1 and 10 in the human ker-atinocyte line HaCaT in ras-transfected tumorigenic clones. Differentiation40, 42–54.
45.
BreitkreutzD., StarkH-J., PleinP., BaurM., & FusenigN.E. (1993). Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin ker-atinocytes (HaCaT-ras) retinoic acid and extracellular Ca2+. Differentiation54, 201–207.
46.
FusenigN.E. (1994). Cell culture models: reliable tools in pharmacotoxicology. In Cell Culture in Pharmaceutical Research (ed. FusenigN.E., & GrafH.), pp. 1–7. Berlin, Germany: Springer Verlag.
47.
BarkerJ.N.W.N., MitraR.S., GriffithsC.E.M., DixitV.M., & NickoloffB.J. (1991). Ker-atinocytes as initiators of inflammation. Lancet337, 211–214.
48.
DeLeoV.A., CarverM.P., HongJ., FungK., KongB., & DeSalvaS. (1996). Arachidonic acid release: an in vitro alternative for dermal irritancy testing. Food and Chemical Toxicology34, 167–176.
49.
GuenicheA., & PonecM. (1993). Use of human skin cell cultures for the estimation of potential skin irritants. Toxicology in Vitro7, 15–24.
50.
Müller-DeckerK., FurstenbergerG., & MarksF. (1994). Keratinocyte-derived pro-inflammatory key mediators and cell viability as in vitro parameters of irritancy: a possible alternative to the Draize skin irritation test. Toxicology and Applied Pharmacology127, 99–108.
51.
RheinwaldJ.G., & GreenH. (1975). Serial cultivation of strains of human epidermal ker-atinocytes: the formation of keratinizing colonies from single cells. Cell6, 331–344.
52.
BoyceS.T., & HamG. (1985). Cultivation, frozen storage and clonal growth of normal human epidermal keratinocytes in serum-free media. Journal of Tissue Culture Methods9, 83–93.
53.
LawrenceJ.N., StarkeyS., DicksonF.M., & Ben-fordD.J. (1996). Use of human and rat ker-atinocyte cultures to assess skin irritation potential. Toxicology in Vitro10, 331–340.
54.
OsborneR., & PerkinsM.A. (1991). In vitro skin irritation testing with human skin cultures. Toxicology in Vitro5, 563–567.
55.
RuttenA.A.J.J.L., Béquet-PasseleqoB.G.A.G.G., & KoëterH.B.W.M. (1990). Two-compartment model for rabbit skin organ culture. In Vitro25, 353–360.
56.
ParishW.E. (1985). Relevance of in vitro tests to in vivo acute skin inflammation: potential in vitro applications of skin keratome slices, neutrophils, fibroblasts, mast cells and macrophages. Food and Chemical Toxicology23, 275–285.
57.
ParishW.E. (1986). Evaluation of in vitro predictive tests for irritation and allergic sensitization. Food and Chemical Toxicology24, 481–494.
58.
KaoJ.K., HallJ., & HollandJ.M. (1983). Quantification of cutaneous toxicity: an in vitro approach using skin organ culture. Toxicology and Applied Pharmacology68, 206–217.
59.
GalliC.L., & MarinovichM. (1990). In vitro markers of skin toxicity. In NATO ASI Series, Vol. 181, Skin Pharmacology and Toxicology. Recent Advances (ed. GalliC.L., HensbyC.N., & MarinovichM.), pp. 165–179. New York, USA: Plenum Press.
60.
BartnikF.G., & PittermannW.F. (1994). Skin organ culture for the study of skin irritancy. In Alternative Methods in Toxicology, Vol. 10, In Vitro Skin Toxicology (ed. RougierA., GoldbergA.M., & MaibachH.I.), pp. 171–181. New York, USA: Mary Ann Liebert.
61.
NakamuraM., RikimaruT., YanoT., MooreG., PulaP.J., SchofieldB.H., & DannenbergA.M. (1990). Full-thickness human skin explants for testing the toxicity of topically applied chemicals. Journal of Investigative Dermatology95, 325–332.
62.
Monteriro-RiviereN.A., InmanA.Q., QiaoG., SniderT.H., BlankJ.A., & HobsonD.W. (1997). Comparison of in vitro human skin equivalent models to normal human skin for dermatological research. Perspectives in Percutaneous Penetration5, 65.
63.
PonecM. (1991). Human epidermis reconstructed on de-epidermized dermis: expression of differentiation-specific markers and lipid composition. Toxicology in Vitro5, 597–606.
64.
SimonettiO., HoogstraateA.J., BilaikW., KempenaarJ.A., SchrijversA.H.G., BoddéH.E., & PonecM. (1995). Visualization of diffusion pathways across the stratum corneum of native and in vitro reconstructed epidermis by confocal laser scanning microscopy. Archives of Dermatological Research87, 465–473.
65.
Van de SandtJ.J.M., MaasW.J.M., DoorninkP.C., & RuttenA.A.J.J.L. (1995). Release of arachidonic and linoleic acid metabolites in skin organ cultures as characteristics of in vitro skin irritancy. Fundamental and Applied Toxicology25, 20–28.
66.
CohenC., Selvi-BignonC., BarbierA., RougierA., LacheretzF., & RoguetR. (1994). Measurement of proinflammatory mediator production by cultured keratinocytes: a predictive assessment of cutaneous irritation In Alternative Methods in Toxicology, Vol. 10, In Vitro Skin Toxicology (ed. RougierA., GoldbergA.M., & MaibachH.I.), pp. 83–96, New York, USA: Mary Ann Liebert.
67.
RosdyM., & ClaussL.C. (1990). Complete human epidermal cell differentiation in chemically defined medium at the air–liquid interface on inert filter substrates. Journal of Investigative Dermatology95, 409–414.
68.
TinoisE., TiollierJ., GaucherandM., DumasH., TardyM., & ThivoletJ. (1991). In vitro and post-transplantation differentiation of human keratinocytes grown on human type IV collagen film of a bilayered dermal substitute. Experimental Cell Research193, 310–331.
69.
RegnierM., AsselineauD., & LenoirM.C. (1990). Human epidermis reconstructed on dermal substrates in vitro: an alternative to animals in skin pharmacology. Skin Pharmacology3, 70–85.
70.
BellE., ParenteauN., GayR., NolteC., KempP., EksteinB., & JohnsonE. (1991). The living skin equivalent: its manufacture, its organotypic properties and its response to irritants. Toxicology in Vitro5, 591–596.
71.
NaughtonG.K., JacobL., & NaughtonB.A. (1989). A physiological model for in vitro toxicity studies. In Alternative Methods in Toxicology, Vol. 7, In Vitro Skin Toxicology (ed. GoldbergA.M.), pp. 335–343. New York, USA: Mary Ann Liebert.
72.
BoyceS., MichelS., ReichertU., ShrootB., & SchmidtR. (1990). Reconstructed skin from cultured human keratinocytes and fibroblasts on a collagen-glycosaminoglycan biopolymer substrate. Skin Pharmacology2, 136–143.
73.
PonecM. (1992). In vitro cultured human skin cells as alternatives to animals for skin irritancy screening. International Journal of Cosmetic Sciences14, 245–264.
74.
PonecM. (1996). In vitro models to predict skin irritation. In The Irritant Contact Dermatitis Syndrome (ed. van der ValkP.G.M., & MaibachH.I.), pp. 335–341. Boca Raton, FL, USA: CRC Press.
75.
PonecM., WeerheimA., KempenaarJ., MulderA., GoorisG.S., BouwstraJ., & MommaasA.M. (1997). The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. Journal of Investigative Dermatology109, 348–355.
76.
ECETOC (1990). ECETOC Monograph 15: Skin Irritation, 77 pp. Brussels, Belgium: European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC).
77.
TatnallF.M., LeighI.M., & GibsonJ.R. (1990). Comparative study of antiseptic toxicity on basal keratinocytes, transformed human keratinocytes and fibroblasts. Skin Pharmacology3, 157–163.
78.
PetraliJ.P., & Oglesby-MegeeS. (1997). Toxicity of mustard gas skin lesions. Microscopical Research Techniques37, 221–228.
79.
HelmanR.G., HallJ.W., & KaoJ.Y. (1986). Acute dermal toxicity: in vivo and in vitro comparisons in mice. Fundamental and Applied Toxicology7, 94–100.
80.
Van de SandtJ.J.M., & RuttenA.A.J.J.L. (1995). Differential effects of chemical irritants in rabbit and human skin organ cultures. Toxicology in Vitro9, 157–168.
81.
PonecM., & KempenaarJ. (1995). Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacology8, 49–59.
82.
BoelsmaE., TanojoH., BoddéH.E., & PonecM. (1996). Assessment of the potential irritancy of oleic acid on human skin: evaluation in vitro and in vivo. Toxicology in Vitro10, 729–742.
83.
BossJ.D., & KapsenbergM.L. (1993). The skin immune system: progress in cutaneous biology. Immunology Today14, 75–78.
84.
McKenzieR.C., & SauderD.N. (1990). The role of keratinocyte cytokines in inflammation and immunity. Journal of Investigative Dermatology95, Suppl., 105–107.
85.
WilliamsI.R., & KupperT.S. (1996). Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sciences58, 1485–1507.
86.
KupperT.S. (1990). Immune and inflammatory processes in cutaneous tissue: mechanisms and speculations. Journal of Clinical Investigation86, 1783–1789.
87.
KupperT.S., & GrovesR.W. (1995). The interleukin-1 axis and cutaneous inflammation. Journal of Investigative Dermatology105, Suppl., 62–66.
88.
SauderD.N., & PastoreS. (1993). Cytokines in contact dermatitis. American Journal of Contact Dermatitis4, 215–224.
89.
RoguetR., CohenC., DossouG., & RougierA. (1994). A reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds. Toxicology in Vitro8, 283–291.
90.
LusterM.I., WilmerJ.L., GermolecD.R., SpaldingJ., YoshidaT., GaidoK., SimeonovaP.P., BurlesonF.G., & BruccoleriA. (1995). Role of keratinocyte-derived cytokines in chemical toxicity. Toxicology Letters82/83, 471–476.
91.
DykesP.J., EdwardsM.J., O'DonovanM.R., MerrettV., MorganH.E., & MarksR. (1991). In vitro reconstruction of human skin equivalents as potential indicators of cutaneous toxicity. Toxicology in Vitro5, 1–8.
92.
RogiersV., BallsM., BasketterD., BerardescaE., EdwardsC., EisnerP., EnnenJ., LévêqueJ.L., LódenM., MassonP., ParraJ., PayeM., PiérardG., RodriguesL., SchaeferH., SalterD., & ZuangV. (1999). The potential use of non-invasive methods in the assessment of cosmetic products. The report and recommendations of ECVAM workshop 36. ATLA27, 515–537.
93.
OsborneS., MayerF.K., SpakeA., RosdyM., DeWeverB., EttlinR.A., & CordierA. (1999). Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles. Cell Biology and Toxicology15, 121–135.
94.
RoguetR., CohenC., RoblesC., CourtellemontP., TolleM., GuillotJ.P., & Pouradier DuteilX. (1998). An interlaboratory study of the reproducibility and relevance of EpiskinTM, a reconstructed human epidermis, in the assessment of cosmetics irritancy. Toxicology in Vitro12, 295–304.
95.
FentemJ.H., BothamP.A., EarlL.K., RoguetR., & van de SandtJ.J.M. (1999). Prevalidation of in vitro tests for acute skin irritation. ATLA27, Special Issue, 346A.
96.
GibbsS., VicanovaJ., BouwstraJ., ValstarD., KempenaarJ., & PonecM. (1997). Culture of reconstructed epidermis in a defined medium at 33°C shows a delayed epidermal maturation, prolonged lifespan and improved stratum corneum. Archives of Dermatological Research289, 585–595.
97.
VicanovaJ., BoelsmaE., MommaasA.M., KempenaarJ.A., ForslindB., PallonJ., EgelrudT., KoertenH.K., & PonecM. (1998). Normalization of epidermal calcium distribution profile in reconstructed human epidermis is related to improvement of terminal differentiation and stratum corneum barrier formation. Journal of Investigative Dermatology111, 97–106.